secwatch / observer
8-K filed July 19, 2023, 7:59 PM ET ticker ELV CIK 0001156039
earnings confidence high sentiment positive materiality 0.85

Elevance Health Q2 GAAP EPS $7.79, adj. EPS $9.04; raises FY2023 guidance

Elevance Health, Inc.

2023-Q2 EPS reported $16.10 revenue$85,844,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Elevance Health, Inc. reported 2023 results: EPS GAAP net income to be greater than $29.09 per share in 2023, and adjusted net income to be greater than $32.85 per share. Guidance raised.

Period
2023
EPS
GAAP net income to be greater than $29.09 per share in 2023, and adjusted net income to be greater than $32.85 per share
Guidance
raised
Result
guidance update
Exact text from the filing
Given the strong performance in the first half of the year and momentum across Elevance Health, we now expect GAAP net income to be greater than $29.09 per share in 2023, and adjusted net income to be greater than $32.85 per share.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Elevance Health, Inc. reported the quarter ended June 30, 2023 results: revenue $43.4 billion, EPS $7.79 per share.

Period
the quarter ended June 30, 2023
Revenue
$43.4 billion
EPS
$7.79 per share
Result
reported results
Exact text from the filing
Second quarter GAAP net income was $7.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $9.04* per share. • Operating revenue grew 12.7% year-over-year to $43.4 billion
View on SEC.gov

Browse all earnings releases →

Elevance Health, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-189147
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.